Aeluma Inc.

03/20/2026 | Press release | Distributed by Public on 03/20/2026 15:05

Material Agreement (Form 8-K)

Item 1.01. Entry into a Material Definitive Agreement.

On March 20, 2026, Aeluma, Inc. (the "Company"), entered into a Sales Agreement (the "Agreement") with Roth Capital Partners, LLC, as representative of the agents (the "Representative"), Craig-Hallum Capital Group LLC, Northland Securities, Inc. and The Benchmark Company, LLC (collectively, the "Agents"). Pursuant to the terms of the Agreement, the Company may sell from time to time to or through the Agents shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), having an aggregate sales price of up to $50.0 million (the "Shares"). Immediately prior to the filing of this Current Report on Form 8-K, the Company filed a prospectus supplement with the Securities and Exchange Commission (the "SEC") with respect to the offering of up to $50.0 million of Shares pursuant to the Agreement. Any Shares will be issued pursuant to the Company's shelf registration statement on Form S-3 (Registration No. 333-289135), which was declared effective by the SEC on August 8, 2025.

The Company is not obligated to sell, and the Agents are not obligated to buy or sell, any Shares under the Agreement. No assurance can be given that the Company will sell any Shares under the Agreement, or, if it does, as to the price or number of Shares that it sells or the dates when such sales will take place.

Pursuant to the terms of the Agreement, the Company agreed to indemnify the Agents against certain liabilities, including under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, or to contribute to payments that the Agents may be required to make because of such liabilities. The Company and the Agents may each terminate the Agreement upon 5 business days' prior written notice as provided in the Agreement.

Sales of the Shares, if any, will be made by means of ordinary brokers' transactions on the Nasdaq Capital Market at market prices or as otherwise agreed by the Company and the Agents. There is no obligation to purchase the Shares on a principal basis pursuant to the Agreement, except as otherwise agreed by the Agents and the Company. The description of the Agreement contained in this Current Report on Form 8-K does not purport to be complete and is qualified in its entirety by reference to the Agreement, filed as Exhibit 1.1 to this Current Report on Form 8-K.

A copy of the legal opinion and consent of Faegre Drinker Biddle & Reath LLP relating to the validity of the issuance and sale of the Shares is attached as Exhibit 5.1 to this Current Report on Form 8-K.

Aeluma Inc. published this content on March 20, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 20, 2026 at 21:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]